Vitamin K3 Inyectable IM and IV 50mg/5mL Vial Valeant Laboratories

Pharmaceutical Form and Formulation: The vial contains: Sodium bisulfite of menadione Vitamin K3 …………. 50 mg cbp vehicle ………………………………………… …5ml Therapeutic indications: Treatment and prevention of hypoprothrombinemia and deficiency of vitamin K-dependent coagulation factors. Absorption and synthesis deficiency of vitamin K due to malabsorption syndromes, antibiotic therapy, prolonged diarrhea, obstructive jaundice, intestinal resection. Hypoprothrombinemia secondary to salicylates, sulfonamide. Coumarin anticoagulant poisoning. Contraindications: hypersensitivity Glucose 6-phosphate dehydrogenase deficiency. Secondary and adverse reactions: Intravenous (I.V.) administration may cause flushing of the load and diaphoresis; intramuscular (I.M.) may cause pain and nodule formation at the application site. In neonates it can cause hyperbilirubinemia and hemolytic anemia. Hypersensitivity may develop. Presentations: Box with a 5 ml vial. Dosage and route of administration: One intramuscular (IM) or intravenous (IV) vial every 24 hours.